Abstract
Purpose
To establish whether in critically ill patients without sepsis at intensive care unit (ICU) admission the percentage immature platelet fraction (IPF%) is a cellular marker predicting sepsis to verify a possible correlation between IPF% changes and manifest sepsis and describe the IPF% time course after ICU admission.
Methods
Prospective, observational 7-day study of 64 adult patients admitted to a general ICU at a University Hospital with no sepsis criteria. We measured daily IPF%, procalcitonin (PCT), C-reactive protein, platelets, white blood cell count and coagulation variables. Thirty-one patients with sepsis at ICU admission were studied as controls.
Results
The only variable we tested at ICU admission that predicted sepsis was plasma IPF% (p < 0.001; >4.7 %: sensitivity 56.2 % IC 37.7–73.6; specificity 90.0 % IC 73.4–97.8). IPF% and PCT values were higher for the patients who had sepsis at admission and during the study than in patients in whom sepsis never developed (IPF%: p = 0.017; PCT: p = 0.030). Among the outcome variables, logistic regression was identified as the only variable related to the development of sepsis, IPF% (r = 0.51; p = 0.004). In patients who developed sepsis IPF% was inversely correlated with platelet count (r = −0.60; p < 0.001) and had high values before sepsis became manifest, decreasing significantly on the 2nd day thereafter.
Conclusions
In patients without sepsis at ICU admission IPF% increases before sepsis becomes manifest. Measuring IPF% through an easily available technology can therefore provide an early cellular marker predicting the development of sepsis.
Similar content being viewed by others
References
Ayres SM (1985) SCCM’S new horizons conference on sepsis and septic shock. Crit Care Med 13:864–866
The EPISEPSIS Study group (2004) EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 30:580–588
Surviving Sepsis Campaign and the Institute for Healthcare Improvement (2006) Severe sepsis bundle. Available at http://www.ihi.org/IHI/Topics/Critical Care/Sepsis/Tools/Severe Sepsis Bundle.htm
Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J, Geneva Sepsis Network (2001) Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically Ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164:396–402
Müller B, Becker KL, Schächinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R (2000) Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28:977–983
Dhainaut JF (2005) Re-establishing organ function in severe sepsis: targeting the microcirculation. Crit Care 9:S1–S2
Abraham E, Singer M (2007) Mechanism of sepsis-induced organ dysfunction. Crit Care Med 35:2408–2416
Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310
Dhainaut JF, Shorr AF, Macias WL, Kollef MJ, Levi M, Reinhart K, Nelson DR (2005) Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med 33:341–348
Tyml K (2011) Critical Role for Oxidative Stress, Platelets, and coagulation in Capillary Blood Flow Impairment in Sepsis. Microcirculation 18:152–162
Levi M, van der Poll T (2004) Coagulation in sepsis: all bugs bite equally. Crit Care 8:99–100
Kirschenbaum LA, McKevitt D, Rullan M, Reisbeck B, Fujii T, Astiz ME (2004) Importance of platelets and fibrinogen in neutrophil-endothelial cell interactions in septic shock. Crit Care Med 32:1904–1909
Huttunen R, Syrjänen J, Vuento R, Hurme M, Huhtala H, Laine J, Pessi T, Aittoniemi J (2011) Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study. J Intern Med 270:32–40
Di Mario A, Garzia M, Leone F, Arcangeli A, Pagano L, Zini G (2009) Immature platelet fraction (IPF) in hospitalized patients with neutrophilia and suspected bacterial infection. J Infect 59:201–206
Briggs C, Kunka S, Hart D, Oguni S, Machin SJ (2004) Assessment of an immature platelet fraction (IPF%) in peripheral thrombocytopenia. Br J Haematol 126:93–99
Stohlawetz P, Folman CC, von dem Borne AE, Pernerstorfer T, Eichler HG, Panzer S, Jilma B (1999) Effects of endotoxemia on thrombopoiesis in men. Thromb Haemost 81:613–617
Ault KA, Rinder HM, Mitchell J, Carmody MB, Vary CP, Hillman RS (1992) The significance of platelets with increased RNA content (reticulated platelets): a measure of the rate of thrombopoiesis. Am J Clin Pathol 98:637–646
Hong KH, Kim HK, Kim JE, Jung JS, Han KS, Cho HI (2009) Prognostic value of immature platelet fraction and plasma thrombopoietin in disseminated intravascular coagulation. Blood Coagul Fibrinolysis 20:409–414
Brown RE, Rimsza LM, Pastos K, Young L, Saxonhouse MA, Bailey M, Lawrence RM, Sola-Visner MC (2008) Effects of sepsis on neonatal thrombopoiesis. Pediatr Res 64:399–404
Briggs C, Harrison P, Grant D, Staves J, Chavda N, Machin SJ (2000) New quantative parameters on a recently introduced automated blood cell counter – the XE-2100. Clin Lab Haematol 22:345–350
Briggs C, Kunka S, Hart D, Oguni S, Machin SJ (2004) Assessment of an immature platelet fraction (IPF%) in peripheral thrombocytopenia. Br J Haematol 126:93–99
Levi M, van der Poll T, Büller HR (2004) Bidirectional relation between inflammation and coagulation. Circulation 109:2698–2704
Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36:309–332
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874
Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a european/north american multicenter study. JAMA 270:2957–2963
Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710
Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86:1327–1330
Franco RF, de Jonge E, Dekkers PE, Timmerman JJ, Spek CA, van Deventer SJ, van Deursen P, van Kerkhoff L, van Gemen B, ten Cate H, van der Poll T, Reitsma PH (2000) The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation. Blood 96:554–559
van Deventer SJH, Buller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A (1990) Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 76:2520–2526
Secor D, Li F, Ellis CG, Sharpe MD, Gross PL, Wilson JX, Tyml K (2010) Impaired microvascular perfusion in sepsis requires activated coagulation and P-selectin-mediated platelet adhesion in capillaries. Intensive Care Med 36:1928–1934
Zimmerman GA, McIntyre TM, Prescott SM, Stafforini DM (2002) The platelet activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med 30:S294–S301
Dunois-Lardé C, Capron C, Fichelson S, Bauer T, Cramer-Bordé E, Baruch D (2009) Exposure of human megakaryocytes to high shear rates accelerates platelet production. Blood 114:1875–1883
Greinacher A, Selleng K (2010) Thrombocytopenia in the intensive care unit patient. Hematology Am Soc Hematol Educ Program 2010:135–143
Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J (2001) Geneva sepsis network. diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164:396–402
Christ-Crain M, Muller B (2005) Procalcitonin in bacterial infections –hype, hope, more or less? Swiss Med Wkly 135:451–460
Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34:344–353
Cremer M, Paetzold J, Schmalisch G, Hammer H, Loui A, Dame C, Weimann A (2009) Immature platelet fraction as novel laboratory parameter predicting the course of neonatal thrombocytopenia. Br J Haematol 144:619–621
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
De Blasi, R.A., Cardelli, P., Costante, A. et al. Immature platelet fraction in predicting sepsis in critically ill patients. Intensive Care Med 39, 636–643 (2013). https://doi.org/10.1007/s00134-012-2725-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-012-2725-7